RGD Reference Report - miR-182 contributes to cell proliferation, invasion and tumor growth in colorectal cancer by targeting DAB2IP. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

miR-182 contributes to cell proliferation, invasion and tumor growth in colorectal cancer by targeting DAB2IP.

Authors: Li, Xiaoli  Zhang, Xudong  Zhang, Qiuge  Lin, Rui 
Citation: Li X, etal., Int J Biochem Cell Biol. 2019 Jun;111:27-36. doi: 10.1016/j.biocel.2019.04.002. Epub 2019 Apr 8.
RGD ID: 151665166
Pubmed: PMID:30974224   (View Abstract at PubMed)
DOI: DOI:10.1016/j.biocel.2019.04.002   (Journal Full-text)

miR-182 was revealed to be upregulated in colorectal cancer (CRC) and contributed to CRC development. However, the detailed molecular mechanism of miR-182 in the progression of CRC remains largely elusive. Herein, miR-182 was upregulated in CRC serum samples, CRC tissues and cells. miR-182 expression was evidently reduced in postoperative serum samples, compared with preoperative serum samples, whereas miR-182 expression was re-elevated in serum samples from CRC patients who developed postoperative recurrence. Exogenous miR-182 promoted the proliferation, colony formation, increased ki67 level and facilitated the invasion capability of CRC cells by enhancing the expressions of MMP-2 and MMP-9, while inhibition of miR-182 showed the opposite effects. Additionally, miR-182 was demonstrated to target DAB2IP and suppress its expression in CRC cells. Downregulation of miR-182 inhibited CRC tumor growth in vivo by upregulating DAB2IP. Moreover, restoration of DAB2IP attenuated miR-182-mediated activation of the PI3K/Akt/mTOR and Wnt/β-catenin pathways in CRC cells. Taken together, our findings showed that miR-182 exerted its oncogenic role in CRC by targeting DAB2IP, which may be involved in activating the PI3K/Akt/mTOR and Wnt/β-catenin pathways, shedding a novel light on the molecular mechanism of CRC tumorigenesis.



RGD Manual Disease Annotations    Click to see Annotation Detail View

  
Object SymbolSpeciesTermQualifierEvidenceWithNotesSourceOriginal Reference(s)
DAB2IPHumancolorectal cancer treatmentIEP human cells in mouse modelRGD 
Dab2ipRatcolorectal cancer treatmentISODAB2IP (Homo sapiens)human cells in mouse modelRGD 
Dab2ipMousecolorectal cancer treatmentISODAB2IP (Homo sapiens)human cells in mouse modelRGD 

Objects Annotated

Genes (Rattus norvegicus)
Dab2ip  (DAB2 interacting protein)

Genes (Mus musculus)
Dab2ip  (disabled 2 interacting protein)

Genes (Homo sapiens)
DAB2IP  (DAB2 interacting protein)


Additional Information